<?xml version="1.0" encoding="UTF-8"?>
<p>Additionally, atorvastatin and rosuvastatin should be started at the lowest possible dose when coadministered with lopinavir–ritonavir, since these antiviral drugs inhibit CYP3A4, OATTP1B1, and BCRP, which have roles in the metabolism of statins [
 <xref rid="B101-jcm-09-01683" ref-type="bibr">101</xref>]. Beta-blockers—especially metoprolol—should be administered cautiously in patients consuming chloroquine or hydroxychloroquine due to CYP2D6 inhibition [
 <xref rid="B104-jcm-09-01683" ref-type="bibr">104</xref>] and the potential role of hydroxychloroquine in reducing heart rate [
 <xref rid="B105-jcm-09-01683" ref-type="bibr">105</xref>]. 
</p>
